| Original language | English |
|---|---|
| Pages (from-to) | 23-26 |
| Number of pages | 4 |
| Journal | FEBS Letters |
| Volume | 105 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published (in print/issue) - 1 Sept 1979 |
Funding
This work was supportedb y VA Institu~on~ ResearchS upport Grant 549-8000-01;N ational Institutes of Health Grants AM 02700-l 6,1 -ROl-AM 18179 and’l-MOl-RR0063;and contract NOl-AM-62219; CIBA-Geigy Corp., Ardsley, NY; Eli Lilly and Company, Indianapolis, 1N; Dr Karl Thomae GmbH, FRG; Bristol Myers, New York, NY; and the Salk Institute-TexasR esearchF oundation, Houston, TX. J. Michael Conlon is the recipient of a Medical ResearchC ouncil (London) Traveling Fellowship. The authorsw ish to acknowledget he excellentt echnical help of Loretta Clendenen,J ohn Diffie, Helen Gibson, Virginia Harris, Kay McCorkle, Lovie Peace and Danny Sandlin. For secretariala ssistanceth e authorse xpresst heir thanks to SusanF reeman and Jessie Reese.
| Funder number |
|---|
| NOl-AM-62219, AM 02700-l 6,1 -ROl-AM 18179, 549-8000-01 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver